Close Menu

In early online publication this week, Stefanie Dimmeler at Goethe-University Frankfurt showed that a specific miRNA controls angiogenesis in mice. In the work, she and her team found that the miR-17~92 cluster is highly expressed in human endothelial cells and that one in particular, miR-92a, controls angiogenesis. When they overexpressed miR-92a in endothelial cells, it blocked angiogenesis both in vitro and in vivo.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.